Population pharmacokinetics and pharmacogenomics of edoxaban in Japanese adults with atrial fibrillation

被引：0

作者：

Satoshi Ueshima ^{[1
]}

Daiki Hira ^{[1
]}

Sayana Matsuda ^{[2
]}

Rio Michihata ^{[6
]}

Yohei Tabuchi ^{[1
]}

Tomoya Ozawa ^{[1
]}

Hideki Itoh ^{[2
]}

Moritake Iguchi ^{[3
]}

Masaharu Akao ^{[3
]}

Takanori Aizawa ^{[7
]}

Asami Kashiwa ^{[4
]}

Satoshi Shizuta ^{[4
]}

Takeru Makiyama ^{[5
]}

Yoshihisa Nakagawa ^{[5
]}

Minoru Horie ^{[8
]}

Tomohiro Terada ^{[5
]}

Toshiya Katsura ^{[5
]}

机构：

[1] Ritsumeikan University,College of Pharmaceutical Sciences

[2] Shiga University of Medical Science Hospital,Department of Pharmacy

[3] Shiga University of Medical Science,Department of Cardiovascular Medicine

[4] Seta Tsukinowa-Cho,Department of Cardiology

[5] National Hospital Organization Kyoto Medical Center,Department of Cardiovascular Medicine

[6] Kyoto University Graduate School of Medicine,Department of Clinical Pharmacology and Therapeutics

[7] Kyoto University Hospital,Division of Patient Safety

[8] Hiroshima University Hospital,Department of Cardiology

[9] Niigata City General Hospital,undefined

来源：

Journal of Pharmaceutical Health Care and Sciences | / 11卷 / 1期

关键词：

Edoxaban; Pharmacokinetics; Pharmacogenomics; Non-linear mixed-effects modeling; Atrial fibrillation;

D O I：

10.1186/s40780-025-00453-2

中图分类号：

学科分类号：

摘要：

引用

共 50 条

[31] Pharmacokinetics of Direct Oral Anticoagulants in Patients With Atrial Fibrillation and Extreme Obesity
Russo, Vincenzo
Cattaneo, Dario
Giannetti, Laura
Bottino, Roberta
Laezza, Nunzia
Atripaldi, Umberto
Clementi, Emilio
CLINICAL THERAPEUTICS, 2021, 43 (09) : E255 - E263
[32] Parental Atrial Fibrillation and Stroke or Atrial Fibrillation in Young Adults A Population-Based Cohort Study
McAlister, Finlay A.
Yan, Lin
Roos, Leslie L.
Lix, Lisa M.
STROKE, 2019, 50 (09) : 2322 - 2328
[33] The efficacy and safety of edoxaban in non-valvular atrial fibrillation
Szegedi Andrea
Csanadi Zoltan
ORVOSI HETILAP, 2018, 159 (12) : 466 - 469
[34] Edoxaban in Atrial Fibrillation and Venous Thromboembolism—Ten Key Questions and Answers: A Practical Guide
Raffaele De Caterina
Walter Ageno
Giuseppe Boriani
Paolo Colonna
Angelo Ghirarduzzi
Giuseppe Patti
Roberta Rossini
Andrea Rubboli
Piercarla Schinco
Giancarlo Agnelli
Advances in Therapy, 2017, 34 : 620 - 637
[35] Edoxaban for stroke prevention in atrial fibrillation and treatment of venous thromboembolism: an expert position paper
Weiss, Thomas W.
Rohla, Miklos
Dieplinger, Benjamin
Domanovits, Hans
Fries, Dietmar
Vosko, Milan R.
Gary, Thomas
Ay, Cihan
WIENER MEDIZINISCHE WOCHENSCHRIFT, 2018, 168 (5-6) : 133 - 143
[36] Edoxaban: A Comprehensive Review of the Pharmacology and Clinical Data for the Management of Atrial Fibrillation and Venous Thromboembolism
Stacy Z.A.
Call W.B.
Hartmann A.P.
Peters G.L.
Richter S.K.
Cardiology and Therapy, 2016, 5 (1) : 1 - 18
[37] Cost-effectiveness of Apixaban Compared With Edoxaban for Stroke Prevention in Nonvalvular Atrial Fibrillation
Lip, Gregory Y. H.
Lanitis, Tereza
Kongnakorn, Thitima
Phatak, Hemant
Chalkiadaki, Corina
Liu, Xianchen
Kuznik, Andreas
Lawrence, Jack
Dorian, Paul
CLINICAL THERAPEUTICS, 2015, 37 (11) : 2476 - 2488
[38] Efficacy and safety of edoxaban in comparison with dabigatran, rivaroxaban and apixaban for stroke prevention in atrial fibrillation
Skjoth, Flemming
Larsen, Torben Bjerregaard
Rasmussen, Lars Hvilsted
Lip, Gregory Y. H.
THROMBOSIS AND HAEMOSTASIS, 2014, 111 (05) : 981 - 988
[39] Effectiveness and safety of edoxaban in patients with atrial fibrillation:data from the Danish Nationwide Cohort
Nielsen, Peter Bronnum
Larsen, Torben Bjerregaard
Skjoth, Flemming
Sogaard, Mette
Lip, Gregory Y. H.
EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 2021, 7 (01) : 31 - 39
[40] Net clinical benefit of edoxaban versus no treatment in a 'real world' atrial fibrillation population: A modelling analysis based on a nationwide cohort study
Blann, Andrew D.
Banerjee, Amitava
Lane, Deirdre A.
Torp-Pedersen, Christian
Lip, Gregory Y. H.
INTERNATIONAL JOURNAL OF CARDIOLOGY, 2015, 201 : 693 - 698

← 1 2 3 4 5 →